Skip to main content
Caplight Logo









Infiniplex

Infiniplex

Private
IsraelHealthcare & Life Scienceshttps://infiniplex.life

Last Round

Seed

May 31, 2022

Total Funding Raised

$1.1M

Company Overview

Infiniplex operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in May 2022.

Infiniplex is a biotech company that develops liquid biopsy solutions for precision oncology and cancer treatment monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Infiniplex Comparables

Compare Infiniplex with similar companies based on industry and business-model similarity.

Infiniplex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lucence
78%
Predicine
77%
Nucleix
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Infiniplex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 31, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Infiniplex Investors

Notable investors and investment history

Infiniplex investors
InvestorRounds
Terra Venture PartnersSeed
Robert Bosch Venture CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2025

    Grew 38% QoQ, from 8 to 11 employees.

  • May 31, 2022

    $1.1M raised with participation from Robert Bosch Venture Capital.

Book a demo to see all signals

For institutional investors. Book with your work email.

Infiniplex Filings

Explore SEC and related filing metadata, where available.

Infiniplex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Infiniplex's valuation, stock price, and market status.

Is Infiniplex a public or private company?

Infiniplex is a private company.

What is the current stock price of Infiniplex?

Infiniplex is a private company, so its shares have no public market price. Caplight tracks Infiniplex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Infiniplex worth (valuation)?

Valuation information for Infiniplex is not publicly available.

Can I buy Infiniplex stock?

Infiniplex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Infiniplex's last funding round?

Infiniplex's most recent funding round was Seed on May 31, 2022.

Who are the main investors in Infiniplex?

Key investors in Infiniplex include Terra Venture Partners, Robert Bosch Venture Capital.

Will Infiniplex IPO soon?

No public IPO plans have been announced for Infiniplex.

How can I track Infiniplex secondary market activity?

Caplight tracks bids, offers, and trades in Infiniplex's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range14
Year Founded2021
Last FundingMay 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?